HomeANIK • NASDAQ
add
Anika Therapeutics Inc
Previous close
$9.88
Day range
$9.68 - $9.90
Year range
$7.90 - $18.37
Market cap
140.75M USD
Avg Volume
144.07K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 27.82M | -5.89% |
Operating expense | 18.82M | -3.45% |
Net income | -2.33M | 92.22% |
Net profit margin | -8.37 | 91.73% |
Earnings per share | 0.04 | 116.00% |
EBITDA | -1.83M | -3,619.23% |
Effective tax rate | -41.99% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 57.99M | -7.02% |
Total assets | 189.44M | -18.14% |
Total liabilities | 42.63M | -17.29% |
Total equity | 146.80M | — |
Shares outstanding | 14.42M | — |
Price to book | 0.97 | — |
Return on assets | -4.29% | — |
Return on capital | -4.70% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -2.33M | 92.22% |
Cash from operations | 6.87M | — |
Cash from investing | -1.73M | — |
Cash from financing | -13.00K | — |
Net change in cash | 4.82M | — |
Free cash flow | 5.36M | — |
About
Founded
1983
Headquarters
Website
Employees
288
